# Evaluation of Vascular Toxicity of Immune Checkpoint Inhibitors in Patients Head and Neck or Lung Cancer

> **NCT05655663** · NA · UNKNOWN · sponsor: **Centre Henri Becquerel** · enrollment: 30 (estimated)

## Conditions studied

- Head and Neck Cancer
- Lung Cancer

## Interventions

- **OTHER:** Vascular investigation

## Key facts

- **NCT ID:** NCT05655663
- **Lead sponsor:** Centre Henri Becquerel
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-12-20
- **Primary completion:** 2025-02-10
- **Final completion:** 2025-12-20
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2022-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05655663

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05655663, "Evaluation of Vascular Toxicity of Immune Checkpoint Inhibitors in Patients Head and Neck or Lung Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05655663. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*